Sustained Benefits With TransCon PTH in Hypoparathyroidism ...Middle East

Medscape - News
Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated sustained efficacy, safety, and tolerability in a 1-year analysis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Sustained Benefits With TransCon PTH in Hypoparathyroidism )

Also on site :